| Identification | Back Directory | [Name]
L-Alanine, L-cysteinylglycyl-L-leucyl-L-serylglycyl-L-leucylglycyl-L-valyl- | [CAS]
1192864-27-9 | [Synonyms]
L-Alanine, L-cysteinylglycyl-L-leucyl-L-serylglycyl-L-leucylglycyl-L-valyl- | [Molecular Formula]
C32H57N9O11S | [MOL File]
1192864-27-9.mol | [Molecular Weight]
775.91 |
| Chemical Properties | Back Directory | [Boiling point ]
1249.4±65.0 °C(Predicted) | [density ]
1.256±0.06 g/cm3(Predicted) | [pka]
3.41±0.10(Predicted) | [Sequence]
Cys-Gly-Leu-Ser-Gly-Leu-Gly-Val-Ala |
| Hazard Information | Back Directory | [Uses]
CooP is a linear glioblastoma-targeting nonapeptide. CooP binds to the mammary-derived growth inhibitor/fatty acid binding protein 3 (FABP3) in the glioblastoma cells and its associated vasculature. CooP is used for the targeted delivery of chemotherapy and different nanoparticles[1]. | [References]
[1] Abiodun Ayo, et al. Tumor-Targeting Peptides: The Functional Screen of Glioblastoma Homing Peptides to the Target Protein FABP3 (MDGI). Cancers (Basel). 2020 Jul 8;12(7):1836. DOI:10.3390/cancers12071836 |
|
|